About NEPeSMO

Founded in 2017 by two respiratory clinicians following 11 yrs of NHS-led and funded research.

Our Mission

To improve the lives of patients with chronic lung conditions by helping them to predict and prevent lung attacks and avoid hospital admissions.

Our Research

Proprietary prediction algorithms are constructed from patient – specific symptoms, lung function and biomarkers in blood and saliva.

Our Evidence

Clinical studies demonstrated 97% reduction in hospital admissions using predict to prevent intervention as part of proactive self-management.

Our Partners

Patients, clinicians, hospitals, policy makers and Industry provide a robust eco-system to ensure our products remain cutting edge and competitive.

“COPD is third leading cause of death worldwide, exceeded only by heart disease and stroke.”

“COPD is  second major cause of unplanned hospital admissions accounting for 12% of total admissions.”

Predict to Prevent

NEPeSMO offers unique digital bio-clinical remote monitoring for prediction and prevention of lung attacks. Our products have been co-designed with patients and are bespoke to our target market. Proprietary prediction algorithms are constructed from time-series data on symptoms, lung function and biomarkers in blood/saliva supplied by patients using a bespoke App that connects wirelessly to monitoring devices.

pp1

What Our Patients say

Direct quotes from COPD patients using our Predict to Prevent intervention.

qodef-team-image
Chairman
Trevor Phillips

30 years+ experience in pharmaceutical industry, including extensive corporate development roles. Was ex-COO & President US Operations Vectura Group, playing key role in Activaero GmbH acquisition & Skyepharma merger. Is also Executive Chairman of hVIVO Ltd.

qodef-team-image
Co-Founder & COO
Monica Spiteri

Respiratory physician and named inventor on patents. Held executive leadership roles in European Respiratory and British Thoracic Societies. Is external advisor to EC Horizon 2020 Personalising Healthcare and various pharmaceutical companies.

qodef-team-image
Co-Founder & Chief Scientific Officer
Neil Patel

Respiratory physician, named inventor on patents. 10 years’ experience in managing project finances/records and research background in saliva diagnostics and prediction algorithm construction.

qodef-team-image
CTO
Atif Syed

Experienced founder of UK start-up SW company. 15 years+ experience in innovative software solutions and specialist in AI and IoT driven applications in healthcare.

qodef-team-image
Non-Executive Board Director
Roger Heerman

With extensive US and international commercialisation experience in a number of senior roles, including vice president sales and marketing of the US publicly held company Critical Therapeutics, Inc. and vice president, director of client service at McK Healthcare. Currently, EVP of Commercial and Business Development at Vectura Group plc.

We will update our news section soon

Watch this space!

    No posts were found.

Name
Email
Subject
Message
Contact Us For Collaborations, Questions Or To Say Hi

For all enquires related to sales, demos, investment opportunities etc , please contact us using this form.

Registered Office

Leigh Saxton Green Mutual House,

70-Conduit Street, London,

United Kingdom, W1S 2GF